Pressure Ulcers Treatment

Global Pressure Ulcers Treatment Market to Reach US$6.7 Billion by 2030

The global market for Pressure Ulcers Treatment estimated at US$5.4 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Wound Care Dressings, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Active Wound Care Therapies segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 7.0% CAGR

The Pressure Ulcers Treatment market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global "Pressure Ulcers Treatment" Market – Key Trends & Drivers Summarized

 Is Rising Chronic Illness Changing the Dynamics of Pressure Ulcer Management?

The increasing global burden of chronic conditions such as diabetes, obesity, and cardiovascular disease is a primary factor elevating the risk of pressure ulcers, thereby expanding the need for effective treatment solutions. These conditions impair mobility and circulation, leading to prolonged hospital stays and the need for long-term care—both of which are high-risk environments for the development of pressure sores. As healthcare systems face mounting pressure to manage aging populations, the incidence of pressure ulcers continues to climb, especially among elderly patients in nursing homes and immobile individuals in intensive care units. This rising demand has pushed manufacturers to innovate and expand their portfolios, offering a wide range of treatment options that include antimicrobial dressings, advanced foam dressings, negative pressure wound therapy (NPWT) devices, and skin substitutes. Governments and health agencies, particularly in Europe and North America, have also been introducing reimbursement policies and preventive care guidelines to improve outcomes and reduce costs associated with pressure ulcer complications. With the growing emphasis on evidence-based clinical practices, hospitals are adopting integrated wound care systems, further transforming the treatment landscape. This clinical need is also stimulating academic and industrial research, leading to breakthroughs in biomaterials, tissue engineering, and wound monitoring technologies.

Can Technology and Innovation Reshape the Way Pressure Ulcers Are Treated?

Emerging technologies are at the forefront of the transformation occurring in the pressure ulcers treatment market. Innovations such as smart dressings embedded with sensors to monitor pH levels, temperature, and moisture in wounds are significantly enhancing patient outcomes by enabling real-time tracking and early intervention. Likewise, developments in negative pressure wound therapy (NPWT) systems have introduced portable, user-friendly, and cost-efficient models, making outpatient care more feasible. The integration of AI and machine learning in wound assessment tools is further streamlining diagnosis and treatment planning, reducing the time healthcare professionals need to determine the appropriate course of action. Additionally, the growth of telehealth services, particularly accelerated by the COVID-19 pandemic, is now playing a crucial role in monitoring chronic wounds remotely, minimizing hospital visits for vulnerable patients. Startups and established medtech firms alike are increasingly investing in R&D to capitalize on these advancements, giving rise to collaborations with healthcare institutions for clinical trials and product validation. Novel therapies such as stem cell applications and bioengineered skin grafts are also gaining traction, offering alternative solutions for patients with severe or non-healing ulcers. Overall, the infusion of digital and regenerative technologies is rapidly redefining the clinical paradigm for pressure ulcer treatment.

Are Shifting Healthcare Settings and End-User Expectations Driving Change?

Changes in healthcare delivery models and patient expectations are significantly influencing the market. There is a noticeable transition from hospital-centric treatment to home care and outpatient settings, driven by the increasing availability of portable treatment devices and home-use dressings. This shift is not only reducing treatment costs but also empowering patients to take a more active role in their wound care. Moreover, caregivers and healthcare providers are becoming more discerning about the efficacy, ease of use, and safety of treatment products. As a result, there is heightened demand for dressings that promote faster healing with fewer dressing changes, and for products that minimize the risk of infection. The expanding role of pharmacists and community nurses in administering wound care is also boosting the consumption of advanced wound care products outside traditional clinical settings. In addition, the role of private and public insurance providers is evolving, with broader coverage for advanced therapies encouraging their adoption. Regional disparities, however, remain notable—with developed countries benefiting from structured healthcare infrastructure and reimbursement systems, while developing nations face constraints due to high costs and limited access. Nevertheless, awareness campaigns, training programs for caregivers, and government initiatives are gradually bridging these gaps, promoting standardized and timely treatment for pressure ulcers across various demographics and healthcare environments.

The Growth in the Pressure Ulcers Treatment Market Is Driven by Several Factors…

Technological advancements in wound care solutions are among the primary drivers of market expansion. The integration of sensor-enabled dressings, machine learning for wound analysis, and portable NPWT systems is creating new standards for treatment efficiency and accuracy. From an end-use perspective, the increasing demand in long-term care facilities, rehabilitation centers, and home healthcare services is expanding the commercial footprint of pressure ulcer treatment solutions. Changing patient demographics, particularly the rapid growth of the geriatric population, is contributing to higher incidence rates and consequently, a greater need for ongoing wound management. Furthermore, evolving consumer behavior—highlighted by growing awareness about early intervention and product quality—is influencing product development and marketing strategies. Hospital procurement practices are also undergoing transformation, with greater preference for cost-effective, clinically proven, and scalable treatment options. Additionally, regional healthcare reforms, such as value-based care models and incentivized prevention measures, are reshaping purchasing dynamics and care protocols. Competitive dynamics are further intensifying as key players invest heavily in R&D and pursue mergers or strategic partnerships to expand their geographic reach and innovation pipeline. These combined forces—technological innovation, end-user shifts, regulatory momentum, and consumer-centric trends—are powering the sustained and diversified growth of the global pressure ulcers treatment market.

SCOPE OF STUDY:

The report analyzes the Pressure Ulcers Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Wound Care Dressings, Active Wound Care Therapies, Wound Care Devices); End-User (Hospitals, Community Health Centers, Homecare Centers, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• 3M
• Acelity L.P. Inc.
• Advancis Medical UK Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cardinal Health, Inc.
• Coloplast A/S
• ConvaTec Group plc
• Derma Sciences, Inc.
• Essity Aktiebolag (AB)
• Hollister Incorporated
• Integra LifeSciences Corporation
• Medline Industries, Inc.
• Medtronic plc
• Mölnlycke Health Care AB
• MPM Medical, Inc.
• Paul Hartmann AG
• Smith & Nephew plc
• Stryker Corporation
• Urgo Medical

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.